Medical News Cambodia

Share |

Summary

Medical News Cambodia: Latest medical news from Cambodia

Description

References

Latest News

'Ultra Rice' Piloted As Way To Tackle Malnutrition
Tue, 27 Jul 2010 11:00:00 +0100 | Health News from Medical News Today
Ultra Rice, a rice-shaped pasta fortified with vitamins and minerals is "being produced and tested around the world as a potential solution to malnutrition," according to the Seattle Times. Produced by the nonprofit PATH, Ultra Rice is currently being piloted by the Indian and Brazilian governments in lunch programs and by the U.N. World Food Program in Cambodia. Each grain of Ultra Rice is combined with approximately 100 grains of ordinary rice... (Source: Health News from Medical News Today)

Early HAART During TB Treatment Boosts Survival Rate In Co-Infected People
Sat, 24 Jul 2010 07:00:00 +0100 | Health News from Medical News Today
A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard... (Source: Health News from Medical News Today)

NIH-Funded Study Finds Early Haart During TB Treatment Boosts Survival Rate In People Co-Infected With HIV And TB
Fri, 23 Jul 2010 13:07:27 +0100 | Drugs.com - Clinical Trials
BETHESDA, Md., July 16, 2010--A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks... (Source: Drugs.com - Clinical Trials)

Early HAART during TB treatment boosts survival rate in people co-infected with HIV and TB, study finds
Fri, 23 Jul 2010 03:00:00 +0100 | ScienceDaily Headlines
A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. (Source: ScienceDaily Headlines)

Study Suggests Starting HAART Early During TB Treatment in People Co-Infected with HIV and TB Improves Survival Rate
Thu, 22 Jul 2010 23:00:00 +0100 | AIDSinfo At-a-Glance: Offering Information on HIV/---- Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS)
“A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the French National Agency for Research on ---- and Viral Hepatitis, brings physicians closer to optimizing the treatment of severely immunosuppressed individuals with HIV-TB co-infection. The findings were presented … at the XVIII International ---- Conference in Vienna by principal investigators Francois-Xavier Blanc, M.D., Anne...

NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB
Thu, 22 Jul 2010 13:16:00 +0100 | National Institutes of Health (NIH) News Releases
A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the French National Agency for Research on ---- and Viral Hepatitis, brings physicians closer to optimizing the treatment of severely immunosuppressed individuals with HIV-TB co-infection. The findings were presented today at the XVIII International ---- Conference in Vienna by principal investigators Francois-Xavier Blanc, M.D., Anne E. Goldfe...

Borland-Groover staff take aid to Cambodia
Thu, 22 Jul 2010 12:00:16 +0100 | bizjournals.com Health Care:Health Insurance headlines
Two physicians and two nurses from Borland-Groover Clinic in Jacksonville are traveling to Cambodia to oversee the installation of a half-million dollars’ worth of new medical equipment and supplies for a local hospital. (Source: bizjournals.com Health Care:Health Insurance headlines)

Borland-Groover staff take aid to Cambodia
Thu, 22 Jul 2010 12:00:16 +0100 | bizjournals.com Health Care:Biotechnology headlines
Two physicians and two nurses from Borland-Groover Clinic in Jacksonville are traveling to Cambodia to oversee the installation of a half-million dollars’ worth of new medical equipment and supplies for a local hospital. (Source: bizjournals.com Health Care:Biotechnology headlines)

NIH-funded study finds early HAART during TB treatment boosts survival rate in co-infected people
Thu, 22 Jul 2010 04:00:00 +0100 | EurekAlert! - Medicine and Health
(NIH/National Institute of Allergy and Infectious Diseases) A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. (Source: EurekAlert! - Medicine and Health)